RxDoctor Payments Data
★ My doctorsLook up a doctor →

Philip Pizzo

Pediatric Hematology-Oncology · Palo Alto, CANPI 1487789756

Payments from drug & device makers

What this record shows

This record is dominated by other: $2,470,614 of the $2,607,898 with a category attached, or 94.7%. Pfizer accounts for 94.7% of it on its own, with 1 other manufacturer making up the rest. 2022 is the largest year on record at $2,521,648, more than ten times the $28,750 reported in 2020. Among pediatric hematology-oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,607,898in general payments, 2019–2025

Across 20 payments — averaging $130,395 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$2.5M
  • Global Blood Therapeutics, Inc.$137K

What the payments were for

  • Consulting fees$137,2845%
  • Other$2,470,61495%

General payments by program year

20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer8$2,470,614
Global Blood Therapeutics, Inc.12$137,284

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,607,898 in reported general payments places this provider in the 95th percentile of 307 pediatric hematology-oncology providers in California.

See all pediatric hematology-oncology providers in California →

Other pediatric hematology-oncology in Palo Alto

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →